Curated News: Medical Meetings

• share
• favorite_border

Later this month Bar-Ilan University will host an international conference dedicated to the advancement of research, development and education in the field of healthy longevity.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Frieda Robscheit-Robbins Award for Exceptional Achievement in the Advancement of Women in Experimental Pathology is Dr. Martha B. Furie, Professor of Pathology, Microbiology, and Immunology in the School of Medicine at Stony Brook University.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Marilyn G. Farquhar Early Career Award for Exceptional Achievement in the Advancement of Women in Experimental Pathology is Dr. Magali Saint-Geniez, the Head of Age-related Macular Degeneration and Director of Novartis Institutes for Biomedical Research at Novartis Biomedical Research.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Rous-Whipple Award is Dr. Anindya Dutta, Endowed Professor and Chair of the Department of Genetics at the University of Alabama – Birmingham.

• share
• favorite_border

he 2025 recipient of the American Society for Investigative Pathology (ASIP) Outstanding Investigator Award is Dr. Pilar Alcaide, Kenneth and Jo Ann G. Wellner Professor, Director of Tufts Immunology Graduate Program, and Assistant Dean for Faculty Development in the Department of Immunology at the Tufts University School of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Gold-Headed Cane Award is Dr. Fred P. Sanfilippo, Professor of Pathology and Laboratory Medicine, Professor of Health Policy and Management, and Director of the Emory-Georgia Tech Healthcare Innovation Program at the Emory University School of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Robbins Distinguished Educator Award is Dr. Dani S. Zander, MacKenzie Professor and Chair in the Department of Pathology and Laboratory Medicine at the University of Cincinnati College of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology Cotran Early Career Investigator Award is Dr. Onur Kanisicak, an Associate Professor in the Department of Emergency Medicine at the Ohio State University Wexner Medical Center.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Young Scientist Leadership Award is Dr. Nakisha S. Rutledge, a Postdoctoral Fellow in the Prizker School of Molecular Engineering at the Chicago Immunoengineering Innovation Center, University of Chicago.

• share
• favorite_border

Nearly 40 percent of cancer patients who experienced memory loss, brain fog and other cognitive difficulties after radiation treatment for brain metastases regained full neurocognitive function within six months, according to a new analysis by radiation oncology researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

• share
• favorite_border

On October 26, 2024, the National Italian-American Foundation (NIAF) will hold its 49th annual Gala at the Omni Shoreham Hotel in Washington D.C. As part of the weekend's prestigious events, the Sbarro Health Research Organization (SHRO) will host a scientific symposium focused on advancements in pain management.

• share
• favorite_border

CEO of the Mount Sinai Health System and Chair of the Emergency Department for Mount Sinai Queens will be honored for their contributions to health policy and diversity, inclusion, and health equity

• share
• favorite_border

A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. It is the first to quantify tumor changes in glioblastoma patients receiving MRI-guided radiation therapy.

• share
• favorite_border

Surveys from two Baltimore medical centers shed light on what may be fueling enrollment declines

• share
• favorite_border

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy — proton beam therapy or intensity modulated radiation therapy (IMRT) — achieved equally high rates of tumor control with no differences in patient-reported quality of life, according to a first-of-its-kind phase III clinical trial comparing the two technologies. Findings of the PARTIQoL trial will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, phase III RT CHARM trial (Alliance A221505) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.